Objective:

To review current evidence supporting AI-based diabetic retinopathy (DR) screening and outline key considerations for safe, equitable implementation.

Approach:

Key Findings:

• AI systems can effectively replace first-level human graders in diabetic eye screening.
• The NHS program achieved significant reductions in blindness due to systematic screening.
• Variability in algorithm performance highlights the need for standardized evaluation metrics.

Interpretation:

Automated retinal image analysis systems present a promising solution to enhance diabetic retinopathy screening, particularly in underserved populations, but require careful implementation and evaluation.

Limitations:

• Regulatory clearance does not guarantee real-world effectiveness.
• Differences in study populations and methodologies limit cross-study comparisons.
• Quality of images and screening workflows can affect performance outcomes.

Conclusion:

For AI-based screening to be effective, it must be integrated into a robust organizational infrastructure that supports systematic screening and addresses equity in access.

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.